McKinney, Texas, September 27, 2025
News Summary
StatLab Medical Products has launched Diapath signature pathology instruments in the U.S., unveiling new histology equipment designed to enhance productivity, precision, and safety. This launch follows StatLab’s strategic acquisition of Diapath in 2024 and coincides with the National Society of Histotechnology Annual Convention. Initial offerings include the Diapath Donatello Tissue Processor, Galileo Microtome, and Dante Embedding Center, aimed at improving pathology workflows in American laboratories.
McKinney, Texas — StatLab Medical Products has launched Diapath signature pathology instruments in the U.S., bringing new histology equipment into American pathology laboratories and debuting the line at a national industry convention.
Key facts
StatLab Medical Products, based in McKinney, Texas, has launched Diapath signature pathology instruments in the U.S. Initial offerings introduced in the U.S. market include the Diapath Donatello Tissue Processor, Galileo Microtome, and Dante Embedding Center, which are presented as designed to enhance productivity, precision, and safety in pathology workflows.
The launch is part of a broader company plan and follows a recent acquisition. The launch is part of StatLab’s strategic vision following the acquisition of Diapath in 2024 to deliver differentiated histology instrumentation to U.S. laboratories. The release of these instruments coincided with StatLab’s presence at the National Society of Histotechnology Annual Convention in Long Beach, California.
Supporting details
Diapath is an Italian manufacturer specializing in histology and cytology products. The acquisition brought Diapath’s product designs and manufacturing relationships into StatLab’s global network.
StatLab’s CEO, Dae Hong, stated the vision was to expand access to innovative histology instruments globally while also strengthening their presence in the U.S. Company leadership indicated the U.S. launch is an initial step and that additional product introductions are planned.
StatLab CEO emphasized that this launch is just the beginning, with plans for additional Diapath products that will support every step of the pathology workflow. The company framed the rollout as a multi-stage effort to supply instruments that address multiple points in the histology and cytology process.
StatLab offers a complete portfolio of self-manufactured pathology equipment and consumables from ten manufacturing sites across the U.S., U.K., and Europe. That existing manufacturing base is presented as a foundation for integrating Diapath products into distribution and service networks.
Convention timing and market focus
The timing of the launch aligned with StatLab’s debut exhibit at a professional gathering. The launch coincides with their debut at the National Society of Histotechnology Annual Convention in Long Beach, California. The convention provided an opportunity to show the instruments to histotechnologists, laboratory managers, and other pathology professionals from across the country.
Product positioning
The first set of instruments released in the U.S. — the Diapath Donatello Tissue Processor, Galileo Microtome, and Dante Embedding Center — are described as addressing common laboratory priorities: faster throughput, precise sectioning, and safer handling of specimens. These devices are intended to be integrated into existing workflows and offered alongside StatLab’s current portfolio of equipment and consumables.
Background and industry context
Diapath, an Italian manufacturer with a specialization in histology and cytology products, has been supplying instruments and consumables to laboratories in various regions prior to the acquisition. The 2024 acquisition brought Diapath’s product line under StatLab’s ownership and set the stage for introducing those instruments to the U.S. market through StatLab’s distribution and support channels.
For U.S. pathology laboratories, new equipment introductions are evaluated against factors such as throughput gains, maintenance and service availability, integration with existing workflows, staff training requirements, and overall cost of ownership. StatLab’s stated strategy emphasizes using its manufacturing footprint and service network to support deployments.
What comes next
StatLab has indicated that the current product introductions are the start of a phased rollout. Future steps are expected to include additional Diapath products and expanded availability through StatLab’s sales and service teams. The company’s existing manufacturing sites across the U.S., U.K., and Europe are positioned to support supply and after-sales service.
FAQ
What happened?
StatLab Medical Products, based in McKinney, Texas, has launched Diapath signature pathology instruments in the U.S.
Why did StatLab launch these products?
The launch is part of StatLab’s strategic vision following the acquisition of Diapath in 2024 to deliver differentiated histology instrumentation to U.S. laboratories.
Who manufactures the Diapath instruments?
Diapath is an Italian manufacturer specializing in histology and cytology products.
What did company leadership say about the launch?
StatLab’s CEO, Dae Hong, stated the vision was to expand access to innovative histology instruments globally while also strengthening their presence in the U.S.
Which products were introduced first?
Initial product offerings include the Diapath Donatello Tissue Processor, Galileo Microtome, and Dante Embedding Center, designed to enhance productivity, precision, and safety in pathology workflows.
Was the launch timed with any event?
The launch coincides with their debut at the National Society of Histotechnology Annual Convention in Long Beach, California.
Are more products expected?
StatLab CEO emphasized that this launch is just the beginning, with plans for additional Diapath products that will support every step of the pathology workflow.
What manufacturing resources does StatLab have?
StatLab offers a complete portfolio of self-manufactured pathology equipment and consumables from ten manufacturing sites across the U.S., U.K., and Europe.
| Product | Primary purpose | Described benefit |
|---|---|---|
| Diapath Donatello Tissue Processor | Tissue processing for histology | Designed to enhance productivity in pathology workflows |
| Galileo Microtome | Tissue sectioning | Designed to enhance precision in pathology workflows |
| Dante Embedding Center | Embedding specimens for sectioning | Designed to enhance safety in pathology workflows |
Deeper Dive: News & Info About This Topic
HERE Resources
Additional Resources
- Dallas Innovates: StatLab Launches Diapath Pathology Equipment
- Business Wire: StatLab Empowers Growth in Europe
- Dallas Innovates: StatLab Launches New Pathology Slide Printer
- Medical Economics: StatLab Expands European Presence
- Wikipedia: Pathology
Author: STAFF HERE DALLAS WRITER
DALLAS STAFF WRITER The DALLAS STAFF WRITER represents the experienced team at HEREDallas.com, your go-to source for actionable local news and information in Dallas, Dallas County, and beyond. Specializing in "news you can use," we cover essential topics like product reviews for personal and business needs, local business directories, politics, real estate trends, neighborhood insights, and state news affecting the area—with deep expertise drawn from years of dedicated reporting and strong community input, including local press releases and business updates. We deliver top reporting on high-value events such as the State Fair of Texas, Deep Ellum Arts Festival, and Dallas International Film Festival. Our coverage extends to key organizations like the Dallas Regional Chamber and United Way of Metropolitan Dallas, plus leading businesses in telecommunications, aviation, and semiconductors that power the local economy such as AT&T, Southwest Airlines, and Texas Instruments. As part of the broader HERE network, including HEREAustinTX.com, HERECollegeStation.com, HEREHouston.com, and HERESanAntonio.com, we provide comprehensive, credible insights into Texas's dynamic landscape.
